Advertisement
Research Article| Volume 63, ISSUE 1, P137-146, January 1964

Rapid disappearance of C14-labeled serotonin from platelets in patients with carcinoid syndrome

  • Marjorie B. Zucker
    Footnotes
    Affiliations
    From the Division of Experimental Surgery and Physiology and Division of Steroid Metabolism, Sloan-Kettering Institute for Cancer Research New York, N. Y. U.S.A.

    From the Division of Neoplastic Medicine, Montefiore Hospital New York, N. Y. U.S.A.
    Search for articles by this author
  • Leon Hellman
    Affiliations
    From the Division of Experimental Surgery and Physiology and Division of Steroid Metabolism, Sloan-Kettering Institute for Cancer Research New York, N. Y. U.S.A.

    From the Division of Neoplastic Medicine, Montefiore Hospital New York, N. Y. U.S.A.
    Search for articles by this author
  • Barnett Zumoff
    Affiliations
    From the Division of Experimental Surgery and Physiology and Division of Steroid Metabolism, Sloan-Kettering Institute for Cancer Research New York, N. Y. U.S.A.

    From the Division of Neoplastic Medicine, Montefiore Hospital New York, N. Y. U.S.A.
    Search for articles by this author
  • Author Footnotes
    ∗ Present address: American National Red Cross Laboratory, New York University Medical Center, N. Y.
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Disappearance of platelet-bound C14-labeled serotonin was studied in 1 patient with multiple sclerosis, 1 patient with a malignant rectal carcinoid tumor, liver metastases, and normal excretion of 5-hydroxyindole acetic acid (5-HIAA), and 5 patients with malignant gastric or intestinal carcinoid tumors with liver metastases and elevated 5-HIAA excretion. In the subject with multiple sclerosis, the half-life was 2.8 and 1.7 days after in vitro and in vivo labeling, respectively. It was 4.5 days in the patient with rectal carcinoid. In the patients with “functioning” carcinoid tumors, the half-life of platelet serotonin was short (0.12 to 1.5 days) and varied inversely with the quantity of 5-HIAA excreted per day. It is concluded that platelet serotonin exchanges with body depots of the amine.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Humphrey J.H.
        • Teh C.C.
        Absorption of Serotinin (5-HT) and Histamine by Dog Platelets.
        J. Physiol. 1954; 124: 300
        • Zucker M.B.
        • Borrelli J.
        Absorption of Serotonin (5-Hydroxytryptamine) by Canine and Human Platelets.
        Am. J. Physiol. 1956; 186: 105
        • Born G.V.R.
        • Gillson R.E.
        Studies on the Uptake of 5-Hydroxytryptamine by Blood Platelets.
        J. Physiol. 1959; 146: 472
        • Heyssel R.M.
        Determination of Human Platelet Survival Utilizing C14-Labeled Serotonin.
        J. Clin. Invest. 1961; 40: 2134
        • Odell Jr., T.T.
        • Kniseley R.M.
        The Origin, Lifespan, Regulation, and Fate of Blood Platelets.
        in: Progress in Hematology. vol. 3. Grune & Stratton, New York1962: 203
        • Cohen P.
        • Gardner F.H.
        • Barnett G.O.
        Reclassification of the Thrombocytoponias by the Cr51-Labeling Method for Measuring Platelet Lifespan.
        New England J. Med. 1961; 264: 1294
        • Cohen P.
        • Gardner F.H.
        • Barnett G.O.
        Reclassification of the Thrombocytoponias by the Cr51-Labeling Method for Measuring Platelet Lifespan.
        New England J. Med. 1961; 264: 1350
        • Zucker M.B.
        • Ley A.B.
        • Mayer K.
        Studies on Plattelet Life Span and Platelet Depots by Use of DFP32.
        J. Lab. & Clin. Med. 1961; 58: 405
        • Zucker M.B.
        Serotonin (5-Hydroxytryptamine): Hematologic Aspects.
        in: ed. 2. Progress in Hematology. vol. 2. Grune & Stratton, New York1962: 206
        • Sjoerdsma A.
        • Weissbach H.
        • Udenfriend S.
        A Clinical, Physiologic, and Biochemical Study of Patients With Malignant Carcinoid (Argentaffinoma).
        Am. J. Med. 1956; 20: 520
        • Sjoerdsma A.
        • Weissbach H.
        • Terry L.K.
        • Udenfriend S.
        Further Observations of Patients With Malignant Carcinoid (Argentaffinoma).
        Am. J. Med. 1957; 23: 5
        • Des Prez R.M.
        • Horowitz H.I.
        • Hook E.W.
        Effects of Bacterial Endotoxin on Rabbit Platelets. I. Platelet Aggregation and Release of Platelet Factors in Vitro.
        J. Exper. Med. 1961; 114: 857
        • Lowry O.H.
        • Rosebrough N.J.
        • Farr A.L.
        • Randall R.J.
        Protein Measurement With the Folin Phenol Reagent.
        J. Biol. Chem. 1951; 193: 265
        • Oates J.A.
        • Sjoerdsma A.
        A Unique Syndrome Associated With Secretion of 5-Hydroxytryptophane by Metastatic Gastric Carcinoids.
        Am. J. Med. 1962; 32: 333